From: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy
Protein amount in mg (1:1:1)
0.3
1
3
10
30
100
300a
600
1050
1500
Observation time (min)
30b
120